[Prevention and treatment of motion sickness].
D001337:Autonomic Agents / Q000627:therapeutic use*; D004111:Dimenhydrinate / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006919:Hydroxyzine / Q000627:therapeutic use; D008620:Meprobamate / Q000627:therapeutic use; D009041:Motion Sickness / Q000188:drug therapy / Q000517:prevention & control; D009539:Nicotinic Acids / Q000627:therapeutic use; D009966:Orphenadrine / Q000627:therapeutic use; D010076:Oxazepam / Q000627:therapeutic use; D011398:Promethazine / Q000627:therapeutic use; D013577:Syndrome; D013881:Thioridazine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*; D014326:Tropanes / Q000627:therapeutic use
D001337:Autonomic Agents; D006634:Histamine H1 Antagonists; D009539:Nicotinic Acids; D014149:Tranquilizing Agents; D014326:Tropanes; D006919:Hydroxyzine; D010076:Oxazepam; D008620:Meprobamate; D009966:Orphenadrine; D011398:Promethazine; D004111:Dimenhydrinate; D013881:Thioridazine
Zapobieganie i leczenie choroby lokomocyjnej